Finally Exploded! The Real Reason Institutions Swept Up 1 Trillion Won of KOSDAQ... The Korean Stock Market Is Changing. February's Leading Stocks Are 'Right Here' | Director Lee Young-hoon

드디어 터졌다! 기관이 코스닥을 1조 원이나 쓸어 담은 '진짜 이유'... 한국 증시 판이 바뀐다. 2월 주도주는 '바로 여기' | 이영훈 이사
Watch on YouTube ↗  |  January 24, 2026 at 08:00  |  18:29  |  815 Money Talk (815머니톡)
Speakers
Lee Young-hoon — Director
Hwang Yoo-hyun — Private Banker Team Lead, NH Investment & Securities

Summary

Lee Young-hoon, Director at iM Securities, and host Hwang Yu-hyeon review the Korean market after KOSPI briefly touched 5,000. Lee argues investors should focus on growth-sector multiple expansion rather than the index level, expects KOSDAQ relative strength in February after institutions bought about KRW 1 trillion of KOSDAQ shares, and favors biotech, selected semiconductor equipment/materials, secondary battery core minerals, and humanoid robotics with a preference for Hyundai Motor Group. He also sees limited large-correction risk in the first half, with more caution due in the second half.

  • KOSPI briefly touched 5,000 and closed near 4,990.
  • Institutions bought about KRW 1 trillion of KOSDAQ shares.
  • Lee expects KOSDAQ to outperform relatively in February as earnings season ends.
  • KOSDAQ biotech rebounded from a bottom and licensing deals continue.
  • Humanoid robotics remains a leading theme, but peripheral names are riskier.
  • Hyundai Motor Group is preferred for concrete humanoid progress.
  • Secondary battery focus is on core minerals, lithium, and large-cap new-high leaders.
  • First-half correction risk is seen as limited; second-half risk is higher.
Ideas
Lee Young-hoon Director 0:00
Focus on growth sectors' multiple expansion.
Do not fixate on the KOSPI level; the main opportunity is in sectors with strong growth momentum whose multiples can be re-rated as earnings momentum remains strong. The 2026 market should be judged by whether these multiple adjustments occur rather than by index targets.
Lee Young-hoon Director 0:13
Humanoid remains leading; avoid periphery.
Humanoid robot expectations remain alive and the sector should stay one of this year's leading sectors, but investors should focus on core/base names and avoid peripheral or purely thematic stocks.
Lee Young-hoon Director 1:35
Micron multiple re-rating could lift semis.
A US argument that Micron's legacy memory business should receive a 20x P/E rather than the prior roughly 10x multiple points to possible memory semiconductor re-rating; if that is reflected, capital could rotate back into semiconductors.
Lee Young-hoon Director 3:11
KOSDAQ relatively stronger into February.
Earnings season for major Korean companies ends in early February, much of the KOSPI good news is already reflected, and institutions bought about KRW 1 trillion of KOSDAQ shares on policy expectations and to fill underowned bio exposure. KOSDAQ has lagged and should be relatively stronger in February, so watch KOSDAQ from next week.
Lee Young-hoon Director 4:45
KOSDAQ biotech bottomed; stay involved.
KOSDAQ biotech fell too much on noise even though record licensing deals and partnerships continue, and it has rebounded from a meaningful bottom. It remains a growth industry with government support; investors should stay involved even without buying the exact bottom and increase bio allocation once a clear new leader emerges.
Lee Young-hoon Director 9:02
H1 lacks big correction; H2 risk.
A very large correction is unlikely in the first half; investors should focus on making gains while conditions allow, and pay more attention to correction risk later in the second half.
Favor US-exposed Korean semiconductor suppliers.
Within KOSDAQ semiconductor equipment and materials, stock selection matters; he favors companies linked to US local operations or fabs.
Core minerals/lithium lead secondary battery.
The clearest momentum in secondary batteries is in core minerals, especially lithium-related companies with real substance; these companies also have steel exposure, and steel is starting to move. He is concentrating on only a few names rather than expanding across the whole battery sector.
Alteogen leadership fading; wait next leader.
Alteogen had been the bio sector's market leader, but its order flow is likely to disperse and recovery may take time. Investors should watch for the next bio leader before expanding broader bio exposure.
Hyundai Motor Group best humanoid substance.
Among humanoid robot plays, Hyundai Motor Group is the one showing real substance and a credible schedule; he sold peripheral humanoid stocks and retained only Hyundai Motor Group-related holdings.
Rainbow Robotics visible but less preferred.
Rainbow Robotics is one of the visible, clear KOSDAQ robot names and trades with a different texture from general humanoid theme stocks, though Hyundai Motor Group remains his preferred humanoid exposure for substance and schedule.
Hwang Yoo-hyun Private Banker Team Lead, NH Investment & Securities 17:56
Buy large-cap battery new-high leaders.
The stock-picking phase in Korean secondary batteries is almost finished, so investors should focus on large-cap, top market-cap names and stocks already making new highs rather than broadening exposure.
Up Next

This 815 Money Talk (815머니톡) video, published January 24, 2026, features Lee Young-hoon, Hwang Yoo-hyun discussing Korean growth/momentum sectors, Korean humanoid/robotics sector, MU, KOSDAQ Index, KOSDAQ biotech sector, EWY, Korean semiconductor equipment/materials with US local exposure, Korean secondary battery core minerals/lithium, 196170.KQ, 005380.KS, 277810.KQ, Large-cap Korean secondary battery new-high leaders. 12 trade ideas extracted by AI with direction and confidence scoring.

Speakers: Lee Young-hoon, Hwang Yoo-hyun  · Tickers: Korean growth/momentum sectors, Korean humanoid/robotics sector, MU, KOSDAQ Index, KOSDAQ biotech sector, EWY, Korean semiconductor equipment/materials with US local exposure, Korean secondary battery core minerals/lithium, 196170.KQ, 005380.KS, 277810.KQ, Large-cap Korean secondary battery new-high leaders